Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B8QA
|
||||
Former ID |
DIB000141
|
||||
Drug Name |
RP-66055
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cerebral infarction [ICD10:I63] | Terminated | [545484] | ||
Company |
Rhone-Poulenc SA
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H22FN3S
|
||||
Canonical SMILES |
c1(=N)n(c2c(s1)cc(OC(F)(F)F)cc2)CCN1CCN(c2ccc(cc2)F)CC1<br />.Cl.Cl
|
||||
CAS Number |
CAS 133783-43-4
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Modulator | [533787] | |
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.